Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma.

@article{Xia2013SafetyOL,
  title={Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma.},
  author={Ying Xia and Christina M. L. Kelton and Liang Xue and Jeff J. Guo and Boyang Bian and Patricia R. Wigle},
  journal={Therapeutic advances in drug safety},
  year={2013},
  volume={4 6},
  pages={254-63}
}
The introduction of long-acting beta agonists (LABAs) was considered a major advance in bronchodilator therapy for adult, as well as pediatric, patients with asthma. However, the use of LABAs has raised safety concerns, especially the potential for severe asthma exacerbations (SAEs) resulting in hospitalizations or even death. Meanwhile, the use of inhaled corticosteroids (ICSs), a cornerstone in the treatment of mild-to-severe persistent asthma, has been associated with growth suppression in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS